Latest industry research report on: Global Anxiety Disorders and Depression Treatment Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Growth to 2022
Depression and Anxiety Disorders are the most common psychiatric disorders affecting a huge population across the globe. Depression; is related to a state Of emotion that further affects actions, thoughts and sometimes the sleeping pattern Of the concerned person. Depression is the most common type Of mental disorder affecting nearly 350 million patients Of varied scale age groups, whereas, anxiety is a reaction to stress. Extreme level Of anxiety result in anxiety disorders which include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic based stress disorder.
The rising geriatric population, reduced side effects and greater efficacy Of new/innovative drugs along with the accelerating prevalence Of anxiety & depression disorders are contributing towards the growth Of this market. However, patent expiry for majority Of the drugs, dry pipeline for the novel drugs, mental disorders that are drug-resistant and growing numbers Of different generic drugs are analysed to impede the anxiety disorders and depression treatment market growth. The prospect Of innovations and developments in herbal remedies with an improved distribution network is Offers potential opportunities for the key participants.
Get Free Sample Report Of Anxiety disorders and depression treatment Market :http://www.custommarketinsights.com/world-anxiety-disorders-depression-treatment-market-/102571#cs_tabs_request_for_sample
The global anxiety disorders and depression treatment market is segmented on the basis Of drug class, pipeline analysis and geography. The drug class segment is further categorized into SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers and Others. On the basis Of pipeline analysis, the market is segmented into Brintellix (Vortioxetine – Lu AA21004), ALKS-5461 and Brexpiprazole (OPC-34712).
The progressive outcomes Of clinical trials for the related drugs and their anticipated commercialization in the forecast period will drive the growth for anxiolytic and antidepressant drugs in the future. Geographically, the global anxiety disorders and depression treatment market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America accounts for the largest market share, contributed by the U.S. due to the presence Of various branded formulations influencing the market dynamics extensively.
Have Any Query? Ask Our Expert @http://www.custommarketinsights.com/world-anxiety-disorders-depression-treatment-market-/102571#cs_tabs_enquiry_for_buying
Key companies prOfiled in this market include Eli Lilly and Company, Forest Laboratories, Inc., AstraZeneca PLC, SanOfi-Aventis, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson and others. Recent developments, Clinical research, geographical expansion and enhanced distribution networks are the key strategies adopted by the key participants.
KEY MARKET SEGMENTS.
The global anxiety disorders and depression treatment Market is segmented into three major categories: drug class, pipeline analysis and geography.
MARKET BY DRUG CLASS
MARKET BY GEOGRAPHY
About Custom Market Insights:
Market Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.
Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.
What makes us different from our competitors?
Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651